GP73: the key to unlocking immunotherapies efficacy in solid tumors?
Resident Golgi protein 73 (GP73) is expressed in many healthy tissues, however overexpression is associated with both viral infections and cancer. As an oncoprotein, GP73 drives tumor progression and plays a fundamental role in immune regulation. A recent publication illustrates a role for GP73 in T...
Saved in:
| Main Authors: | Alan L Parker, Rebecca J Bayliss |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2025-05-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| Online Access: | https://jitc.bmj.com/content/13/5/e011989.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
GP73-mediated secretion of PKM2 and GP73 promotes angiogenesis and M2-like macrophage polarization in hepatocellular carcinoma
by: Shujie Wang, et al.
Published: (2025-02-01) -
Correction: GP73-mediated secretion of PKM2 and GP73 promotes angiogenesis and M2-like macrophage polarization in hepatocellular carcinoma
by: Shujie Wang, et al.
Published: (2025-05-01) -
Serum Golgi protein 73 (GP73) is a diagnostic and prognostic marker of hepatocellular carcinoma
by: Qian Wang, et al.
Published: (2025-04-01) -
GP73 reinforces cytotoxic T-cell function by regulating HIF-1α and increasing antitumor efficacy
by: Xiaoli Yang, et al.
Published: (2025-01-01) -
Ultrasonic Parameters as Biomarkers for Tumor Staging and Aggressiveness in Breast Cancer: Correlation with GP73 and miR-27a
by: Tao ZY, et al.
Published: (2025-06-01)